| 1. |
楊紅, 何瑤, 王玉芳, 等. 腸型貝赫切特綜合征(腸白塞病)診斷和治療共識意見. 胃腸病學, 2022, 27(12): 723-733.
|
| 2. |
Gomollón F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part1: diagnosis and medical management. J Crohns Colitis, 2017, 11(1): 3-25.
|
| 3. |
Jo JH, Park SJ, Cheon JH, et al. Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Beh?et's disease. J Gastroenterol Hepatol, 2018, 33(2): 375-379.
|
| 4. |
Valenti S, Gallizzi R, De Vivo D, et al. Intestinal Beh?et and Crohn’sdisease: two sides of the same coin. Pediatr Rheumatol Online J, 2017, 15(1): 33.
|
| 5. |
Haneishi Y, Furuya Y, Hasegawa M, et al. Inflammatory bowel diseases and gut microbiota. Int J Mol Sci, 2023, 24(4): 3817.
|
| 6. |
孫鹿希, 鄭文潔. 腸道菌群與白塞病發病的關聯. 中華臨床免疫和變態反應雜志, 2019, 13(5): 411-417.
|
| 7. |
Watanabe K, Tanida S, Inoue N, et al. Evidence-based diagnosis and clinical practice guidelines for intestinal Beh?et’s disease 2020 edited by intractable diseases, the health and labour sciences research grants. J Gastroenterol, 2020, 55(7): 679-700.
|
| 8. |
Tanida S, Inoue N, Kobayashi K, et al. Adalimumab for the treatment of Japanese patients with intestinal Beh?et’s disease. Clin Gastroenterol Hepatol, 2015, 13(5): 940-948. e3.
|
| 9. |
劉愛玲, 呂紅, 錢家鳴. 英夫利西單抗治療炎癥性腸病失應答. 協和醫學雜志, 2015, 6(2): 140-145.
|
| 10. |
蔡方嵐, 潘小麗, 田梅. 英夫利昔單抗治療腸白塞病伴反復腸瘺一例. 臨床內科雜志, 2024, 41(3): 208-209.
|
| 11. |
李浩霖, 陳舒澤, 王瑛, 等. 腸道菌群優化抗 TNF-α單抗治療炎癥性腸病的研究進展. 現代消化及介入診療, 2024, 29(12): 1391-1394, 1397.
|
| 12. |
Park J, Cheon JH, Park YE, et al. Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Beh?et’s disease. Int J Colorectal Dis, 2017, 32(5): 745-751.
|
| 13. |
盧雪揚, 劉冰熔, 劉丹, 等. 腸白塞病的內鏡特點與臨床特征分析. 胃腸病學和肝病學雜志, 2023, 32(9): 972-976, 981.
|
| 14. |
張喆, 鄭長清, 秦芳芳, 等. 英夫利昔單抗治療類固醇難治性潰瘍性結腸炎的臨床觀察. 廣西醫學, 2020, 42(8): 945-949.
|
| 15. |
Albayrak O, Oray M, Can F, et al. Effect of interferon alfa-2a treatment on adaptive and innate immune systems in patients with Beh?et disease uveitis. Invest Ophthalmol Vis Sci, 2019, 60(1): 52-63.
|
